Yu Wu (Wu Yu)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 26

Top Venues

Journal of cancer research and clinical oncology

Annals of hematology

Cancer medicine

OncoTargets and therapy

Sichuan University West China Hospital

Cancer Research Institute, Kanazawa University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Sichuan University West China Hospital

China

associate professor, Professor :: Department of Hematology

Kanazawa Medical University

Japan

TA, RA :: Division of Bioregulation

Sichuan University West China Hospital

China

resident, chief resident, attending physician :: Department of Hematology

Education History

Cancer Research Institute, Kanazawa University Mar 01 2005 - Mar 15 2009

Japan

PHD :: Division of Bioregulation

Sichuan University West China Medical Center Sep 01 1993 - Jun 30 2000

China

PHD

Publications

Lei Zhao, Jinjun Yang, Mengran Chen, Xinrong Xiang, Hongbing Ma, Ting Niu, Yuping Gong, Xinchuan Chen, Jiazhuo Liu, Yu Wu
Myelomonocytic and monocytic acute myeloid leukemia demonstrate comparable poor outcomes with venetoclax-based treatment: a monocentric real-world study. Annals of hematology 103 (4) (2024)
Xuefeng Li, Yan Yu, Hongbin Yu, Mengran Chen, Xin Zhang, Yu Wu
Minimal residual disease in systemic light chain amyloidosis: a systematic review and meta-analysis. Journal of cancer research and clinical oncology 150 (4) (2024)
Lei Zhao, Jinjun Yang, Mengran Chen, Xinrong Xiang, Hongbing Ma, Ting Niu, Yuping Gong, Xinchuan Chen, Jiazhuo Liu, Yu Wu
Myelomonocytic and monocytic acute myeloid leukemia demonstrate comparable poor outcomes with venetoclax-based treatment: a monocentric real-world study. Annals of hematology 103 (4) (2024)
Xuefeng Li, Yan Yu, Hongbin Yu, Mengran Chen, Xin Zhang, Yu Wu
Minimal residual disease in systemic light chain amyloidosis: a systematic review and meta-analysis. Journal of cancer research and clinical oncology 150 (4) (2024)
Xuefeng Li, Yan Yu, Hongbin Yu, Mengran Chen, Xin Zhang, Yu Wu
Minimal residual disease in systemic light chain amyloidosis: a systematic review and meta-analysis. Journal of cancer research and clinical oncology 150 (4) (2024)
Lei Zhao, Jinjun Yang, Mengran Chen, Xinrong Xiang, Hongbing Ma, Ting Niu, Yuping Gong, Xinchuan Chen, Jiazhuo Liu, Yu Wu
Myelomonocytic and monocytic acute myeloid leukemia demonstrate comparable poor outcomes with venetoclax-based treatment: a monocentric real-world study. Annals of hematology (2024)
Xuefeng Li, Yan Yu, Hongbin Yu, Mengran Chen, Xin Zhang, Yu Wu
Minimal residual disease in systemic light chain amyloidosis: a systematic review and meta-analysis. Journal of cancer research and clinical oncology 150 (4) (2024)
Xuefeng Li, Yan Yu, Hongbin Yu, Mengran Chen, Xin Zhang, Yu Wu
Minimal residual disease in systemic light chain amyloidosis: a systematic review and meta-analysis. Journal of cancer research and clinical oncology 150 (4) (2024)
Xuefeng Li, Yan Yu, Hongbin Yu, Mengran Chen, Xin Zhang, Yu Wu
Minimal residual disease in systemic light chain amyloidosis: a systematic review and meta-analysis. Journal of cancer research and clinical oncology 150 (4) (2024)
Xuefeng Li, Yan Yu, Hongbin Yu, Mengran Chen, Xin Zhang, Yu Wu
Minimal residual disease in systemic light chain amyloidosis: a systematic review and meta-analysis. Journal of cancer research and clinical oncology 150 (4) (2024)
Lei Zhao, Jinjun Yang, Mengran Chen, Xinrong Xiang, Hongbing Ma, Ting Niu, Yuping Gong, Xinchuan Chen, Jiazhuo Liu, Yu Wu
Myelomonocytic and monocytic acute myeloid leukemia demonstrate comparable poor outcomes with venetoclax-based treatment: a monocentric real-world study. Annals of hematology 103 (4) (2024)
Xuefeng Li, Yan Yu, Hongbin Yu, Mengran Chen, Xin Zhang, Yu Wu
Minimal residual disease in systemic light chain amyloidosis: a systematic review and meta-analysis. Journal of cancer research and clinical oncology 150 (4) (2024)
Yunfan Yang, Yang Shu, Yuan Tang, Sha Zhao, Yongqian Jia, Jie Ji, Hongbing Ma, Ting Lin, Ke Zheng, Heng Xu, Yu Wu
RNA sequencing of myeloid sarcoma, shed light on myeloid sarcoma stratification. Cancer medicine (2023)
Jinjun Yang, Lei Zhao, Yu Wu, Ting Niu, Yuping Gong, Xinchuan Chen, Xiaoou Huang, Jiazhuo Liu, Yang Dai, Hongbing Ma
The clinical features and prognostic implications of PTPN11 mutation in adult patients with acute myeloid leukemia in China. Cancer medicine (2023)
Yu Wu, Hong Ding
CAR-T Therapy in Relapsed Refractory Multiple Myeloma. Current medicinal chemistry (2023)
Yang Ou, Yan Yang, Xuefeng Li, Xin Zhang, Lei Zhao, Chenlu Yang, Yu Wu
Arginine metabolism key enzymes affect the prognosis of myelodysplastic syndrome by interfering with macrophage polarization. Cancer medicine (2023)
Jinjun Yang, Lei Zhao, Wen Wang, Yu Wu
All-trans retinoic acid added to treatment of primary immune thrombocytopenia: a systematic review and meta-analysis. Annals of hematology (2023)
Qi Zhang, He Li, Xuelan Chen, Fan Gu, Lanxin Zhang, Lu Zhang, Tong Chen, Qiang Chen, Wentong Meng, Yu Wu, Hong Chang, Ting Liu, Chong Chen, Hongbing Ma, Yu Liu
Identifying STRN3-RARA as a new fusion gene for acute promyelocytic leukemia. Blood (2023)
He Li, Xinrong Xiang, Hong Ding, Jiang Yu, Juan Xu, Ying Yuan, Yu Wu
Differentiation therapy using low-dose venetoclax in a variant acute promyelocytic leukaemia carrying ZBTB16-RARA. British journal of haematology 199 (5) (2022)
Chunli Yang, Jiang Ming, Ziyan Ma, Ji Jie, Lv Shuli, Huang Jie, Yu Wu, Xu Caigang, Zou Liqun
Real-World clinical features and survival outcomes associated with primary gastrointestinal natural killer/T-cell lymphoma from 1999 to 2020. Cancer medicine (2022)
Yang Ou, Yan Yang, Hongbin Yu, Xin Zhang, Min Liu, Yu Wu
The prognostic significance of single-nucleotide polymorphism array-based whole-genome analysis and uniparental disomy in myelodysplastic syndrome. International journal of laboratory hematology 43 (5) (2021)
Chen-Lu Yang, Xin-Rong Xiang, Yu Wu
Armor sign on PET-CT in a young male with non-Hodgkin's lymphoma. International journal of hematology (2021)
Chen-Lu Yang, Neng-Gang Jiang, Li Zhang, Kai Shen, Yu Wu
Relapsed/refractory multiple myeloma-transformed plasma-cell leukemia successfully treated with daratumumab followed by autologous stem cell transplantation. Therapeutic advances in hematology 12 (2021)
Kai-Ni Shen, Wei-Jun Fu, Yu Wu, Yu-Jun Dong, Zhong-Xia Huang, Yong-Qiang Wei, Chun-Rui Li, Chun-Yan Sun, Ye Chen, Hui-Lei Miao, Yue-Lun Zhang, Xin-Xin Cao, Dao-Bin Zhou, Jian Li
Doxycycline Combined With Bortezomib-Cyclophosphamide-Dexamethasone Chemotherapy for Newly Diagnosed Cardiac Light-Chain Amyloidosis: A Multicenter Randomized Controlled Trial. Circulation (2021)
Yunfan Yang, Ting Lin, Tian Dong, Yu Wu
Myelodysplastic syndrome presenting with central diabetes insipidus is associated with monosomy 7, visible or hidden: report of two cases and literature review. Molecular cytogenetics 14 (1) (2021)
Hongmei Luo, Ruixue Sun, Yuhuan Zheng, Jingcao Huang, Fangfang Wang, Dan Long, Yu Wu
PIM3 Promotes the Proliferation and Migration of Acute Myeloid Leukemia Cells. OncoTargets and therapy 13 (2020)

Yu Wu.css-eqlu8i{font-size:small;padding-left:4px;} (Wu Yu)

Publication Activity (10 Years)

Top Topics

Top Venues

Yu Wu (Wu Yu)